About Us

Dr. Lai-Xi Wang

Dr. Wang is the Founder and President of GlycoT Therapeutics LLC. He is a world renowned organic chemist and biochemist with more than 25 years of research experience in carbohydrate chemistry, enzymology, glycobiology, and immunology. He is the inventor of the core chemoenzymatic protein glycosylation technologies that enable the synthesis of homogeneous antibody glycoforms and the construction of site-specific antibody-drug conjugates. Dr. Wang has the expertise, leadership, and motivation necessary to successfully guide GlycoT to fulfill its mission. He has published over 200 peer-reviewed scientific papers, most of them are related to chemoenzymatic synthesis, glycoengineering of therapeutic antibodies, and glyco-immunology. Currently Dr. Wang is a Distinguished University Professor in the Department of Chemistry and Biochemistry, University of Maryland,  College Park.  Dr. Wang was elected as an AAAS Fellow (2014), an ACS Fellow (the American Chemical Society, 2019), and a Fellow of the National Academy of Inventors (2023).

BOD and SAB Memebers

To be updated soon

Research and Development Collaborations
To explore our technology or seek collaboration/partnership, investment opportunities, or if you have any general inquiry for our company, click the "learn more" button.
Learn More